Cargando…

Does the LENT score risk‐stratify patients with malignant pleural mesothelioma? An observational study

BACKGROUND: Malignant pleural mesothelioma (MPM) is a rare, highly aggressive and deadly disease with a poor patient life expectancy. A few years ago, the main challenge was the histological diagnosis of this disease; at present, the search for the best therapeutic strategy is now a priority. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chollet, Bertrand, Guinde, Julien, Laroumagne, Sophie, Dutau, Hervé, Astoul, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169304/ https://www.ncbi.nlm.nih.gov/pubmed/33949775 http://dx.doi.org/10.1111/1759-7714.13987

Ejemplares similares

Prolonged survival after multimodal therapy for pleural mesothelioma: Don't give up the follow-up. A case report
por: Guinde, Julien, et al.
Publicado: (2020)

Anaplastic thyroid carcinoma mimicking a malignant pleural mesothelioma: Clues for diagnosis
por: Capron, Thibaut, et al.
Publicado: (2019)

A novel pleural-bladder pump for the management of recurrent malignant pleural effusions: a feasibility animal study
por: Laroumagne, S., et al.
Publicado: (2020)

Novel pleural-bladder pump in malignant pleural effusions: from animal model to man
por: Astoul, Philippe, et al.
Publicado: (2020)

Advances in pleural infection and malignancy
por: Bedawi, Eihab O., et al.
Publicado: (2021)

Chest ultrasonography to assess the kinetics and efficacy of talc pleurodesis in a model of pneumothorax: an experimental animal study
por: Tazi-Mezalek, Rachid, et al.
Publicado: (2018)

Low lamin A expression in lung adenocarcinoma cells from pleural effusions is a pejorative factor associated with high number of metastatic sites and poor Performance status
por: Kaspi, Elise, et al.
Publicado: (2017)

The necessity of a more aggressive initial surgical treatment in patients with mesothelioma of the testicular tunica vaginalis
por: Brun, Clement, et al.
Publicado: (2019)

The role of LENT and PROMISE scores in predicting survival in malignant pleural effusion
por: Ermin, Sinem, et al.
Publicado: (2022)

Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score
por: Clive, Amelia O, et al.
Publicado: (2014)

Rethought histologic classification of pleural mesothelioma to better treat: go forward from looking back
por: Astoul, Philippe
Publicado: (2020)

Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions
por: Roca, Elisa, et al.
Publicado: (2015)

Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma
por: Bensaid, Douae, et al.
Publicado: (2018)

Prediction modeling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients complicated with malignant pleural effusion
por: Zhang, Shu, et al.
Publicado: (2021)

Pulmonary cement embolism complicating percutaneous kyphoplasty: A case report
por: Naud, Romain, et al.
Publicado: (2020)

“Dancing Eye Syndrome” Secondary to Opsoclonus-Myoclonus Syndrome in Small-Cell Lung Cancer
por: Laroumagne, S., et al.
Publicado: (2014)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Malignant Pleural Mesothelioma—Does Ki67 Make the Grade?
por: Prall, Owen W.J.
Publicado: (2021)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Malignant pleural mesothelioma in situ
por: Ando, Kohei, et al.
Publicado: (2022)

KRAS signaling in malignant pleural mesothelioma
por: Marazioti, Antonia, et al.
Publicado: (2021)

MicroRNA gene expression signatures in long-surviving malignant pleural mesothelioma patients
por: Lin, Ruby C.Y., et al.
Publicado: (2016)

5-hydroxymethylcytosine but not MTAP methylation status can stratify malignant pleural mesothelioma based on the lineage of origin
por: Bosio, Matteo, et al.
Publicado: (2018)

Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience
por: Falanga, Francesco, et al.
Publicado: (2022)

Thoracoscopy in Pleural Malignant Mesothelioma Diagnosis
por: Tassi, G. F., et al.
Publicado: (1997)

Imaging in staging of malignant pleural mesothelioma
por: Truong, Mylene T, et al.
Publicado: (2004)

Hedgehog Signaling in Malignant Pleural Mesothelioma
por: Felley-Bosco, Emanuela, et al.
Publicado: (2015)

Targeting YAP in malignant pleural mesothelioma
por: Zhang, Wen‐Qian, et al.
Publicado: (2017)

Multimodality treatment of malignant pleural mesothelioma
por: Berzenji, Lawek, et al.
Publicado: (2018)

Modern management of malignant pleural mesothelioma
por: Patel, Shivani C, et al.
Publicado: (2016)

Pleural tuberculosis mimicking malignant mesothelioma
por: Dawood, Wajahat, et al.
Publicado: (2019)

Cytomegalovirus infection in malignant pleural mesothelioma
por: Hunter-Schlichting, DeVon, et al.
Publicado: (2021)

Immunotherapeutic Approaches in Malignant Pleural Mesothelioma
por: Terenziani, Rita, et al.
Publicado: (2021)

Advances in Immunotherapy of Malignant Pleural Mesothelioma
por: Liao, Dongying, et al.
Publicado: (2021)

ECM Mechanoregulation in Malignant Pleural Mesothelioma
por: Panzetta, Valeria, et al.
Publicado: (2022)

Circulating biomarkers in malignant pleural mesothelioma
por: Viscardi, Giuseppe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ndrbsbm750o3t5ljt44midg5q2